Sign inGet started

Woody Tracy M

Insider CIK 1638362 · KMPH Chief Commercial Officer · ESPR Director · VSAR Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ESPR Esperion Therapeutics, Inc A Award deriv2025-05-292025-06-0288,000— $088,000SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2024-05-232024-05-2465,000— $065,000SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2023-06-152023-06-1621,000— $021,000SEC↗
ESPR Esperion Therapeutics, Inc A Award2023-06-152023-06-165,150— $033,566SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2022-05-262022-05-2720,000— $020,000SEC↗
ESPR Esperion Therapeutics, Inc A Award2021-05-272021-05-2812,376— $028,416SEC↗
ESPR Esperion Therapeutics, Inc A Award2020-05-282020-05-296,106— $016,040SEC↗
ESPR Esperion Therapeutics, Inc A Award2019-05-292019-05-319,934— $09,934SEC↗
VSAR Versartis, Inc. S Sale2018-03-232018-03-264,345$1.75 $7.6K215,755SEC↗
VSAR Versartis, Inc. A Award2017-12-202017-12-2293,100— $0220,100SEC↗
VSAR Versartis, Inc. A Award2017-10-062017-10-1082,000— $0127,000SEC↗
VSAR Versartis, Inc. A Award deriv2017-03-222017-03-31100,000— $0100,000SEC↗
VSAR Versartis, Inc. A Award2017-03-222017-03-3145,000— $045,000SEC↗
KMPH KEMPHARM, INC A Award deriv2016-02-112016-02-1650,000— $050,000SEC↗
KMPH KEMPHARM, INC A Award deriv2015-05-272015-05-2982,035— $082,035SEC↗